Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -40.90% is in line with its 5-year average of -45.16%, near the high end of its 5-year range (-461.48%–60.47%).
42.21% above its 12-month average of -70.78%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 35.92%.
NET PROFIT MARGIN
-40.90%
NET PROFIT MARGIN AVG TTM
-70.78%
NET PROFIT MARGIN AVG 3Y
-14.46%
NET PROFIT MARGIN AVG 5Y
-45.16%
NET PROFIT MARGIN AVG 10Y
-207.83%
NET PROFIT MARGIN AVG 15Y
-231.24%
NET PROFIT MARGIN AVG 20Y
-221.35%
CURRENT VS TTM AVG
+42.21%
CURRENT VS 3Y AVG
-182.80%
CURRENT VS 5Y AVG
+9.43%
CURRENT VS 10Y AVG
+80.32%
CURRENT VS 15Y AVG
+82.31%
CURRENT VS 20Y AVG
+81.52%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 565 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BioCryst Pharmaceuticals, Inc.
Market Cap
$2.02B
Net Profit Margin
-40.90%
TTM Avg
-70.78%
3Y Avg
-14.46%
5Y Avg
-45.16%
Market Cap
$1.98B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$2.01B
Net Profit Margin
-13.36%
TTM Avg
-6.14%
3Y Avg
-11.71%
5Y Avg
-14.87%
Market Cap
$2.01B
Net Profit Margin
15.03%
TTM Avg
11.31%
3Y Avg
2.06%
5Y Avg
-9.89%
Market Cap
$2.00B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.99B
Net Profit Margin
100.84%
TTM Avg
51.96%
3Y Avg
-5.31%
5Y Avg
-103.82%
Market Cap
$2.05B
Net Profit Margin
-36.51%
TTM Avg
-21.30%
3Y Avg
-316.14%
5Y Avg
-299.31%
Market Cap
$1.98B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$2.10B
Net Profit Margin
-268385.71%
TTM Avg
-9751.05%
3Y Avg
-6580.61%
5Y Avg
-4774.06%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals, Inc. (BCRX) | $2.02B | -40.90% | -70.78% | -14.46% | -45.16% |
| Azenta, Inc. (AZTA)vs › | $1.98B | -20.02% | -19.08% | -29.38% | -13.21% |
| AxoGen, Inc. (AXGN)vs › | $2.01B | -13.36% | -6.14% | -11.71% | -14.87% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.01B | 15.03% | 11.31% | 2.06% | -9.89% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.00B | 0.00% | 0.00% | 0.00% | 0.00% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $1.99B | 100.84% | 51.96% | -5.31% | -103.82% |
| Alvotech (ALVO)vs › | $2.05B | -36.51% | -21.30% | -316.14% | -299.31% |
| Immunome, Inc. (IMNM)vs › | $1.98B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.10B | -268385.71% | -9751.05% | -6580.61% | -4774.06% |
| Addus HomeCare Corporation (ADUS)vs › | $2.10B | 7.13% | 6.55% | 5.96% | 5.57% |
Operating Margin
39.0%
Net Profit Margin
-40.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 35.92% |
| 2026-03-31 | -461.48% |
| 2025-12-31 | 60.47% |
| 2025-09-30 | 8.09% |
| 2025-06-30 | 3.11% |
| 2025-03-31 | 0.02% |
| 2024-12-31 | -20.37% |
| 2024-09-30 | -11.99% |
| 2024-06-30 | -11.59% |
| 2024-03-31 | -38.14% |
| 2023-12-31 | -66.09% |
| 2023-09-30 | -41.67% |
| 2023-06-30 | -91.31% |
| 2023-03-31 | -77.54% |
| 2022-12-31 | -89.94% |
| 2022-09-30 | -56.08% |
| 2022-06-30 | -89.82% |
| 2022-03-31 | -148.62% |
| 2021-12-31 | -37.70% |
| 2021-09-30 | -143.44% |
| 2021-06-30 | -86.47% |
| 2021-03-31 | -337.29% |
| 2020-12-31 | -1506.30% |
| 2020-09-30 | -755.74% |
| 2020-06-30 | -1344.72% |
| 2020-03-31 | -779.58% |
| 2019-12-31 | -6.60% |
| 2019-09-30 | -2117.86% |
| 2019-06-30 | -2598.69% |
| 2019-03-31 | -527.50% |
| 2018-12-31 | -1005.20% |
| 2018-09-30 | -2035.56% |
| 2018-06-30 | -147.64% |
| 2018-03-31 | -648.31% |
| 2017-12-31 | -502.39% |
| 2017-09-30 | -172.76% |
| 2017-06-30 | -544.89% |
| 2017-03-31 | -150.67% |
| 2016-12-31 | -50.13% |
| 2016-09-30 | -148.50% |
| 2016-06-30 | -340.11% |
| 2016-03-31 | -473.69% |
| 2015-12-31 | -394.07% |
| 2015-09-30 | -133.08% |
| 2015-06-30 | 18.97% |
| 2015-03-31 | -222.15% |
| 2014-12-31 | -214.32% |
| 2014-09-30 | -269.64% |
| 2014-06-30 | -999.25% |
| 2014-03-31 | -293.15% |
| 2013-12-31 | -51.38% |
| 2013-09-30 | -334.91% |
| 2013-06-30 | -1482.58% |
| 2013-03-31 | -126.79% |
| 2012-12-31 | -269.52% |
| 2012-09-30 | -168.37% |
| 2012-06-30 | -291.59% |
| 2012-03-31 | -49.52% |
| 2011-12-31 | -252.53% |
| 2011-09-30 | -275.46% |
| 2011-06-30 | -435.64% |
| 2011-03-31 | -239.69% |
| 2010-12-31 | -61.11% |
| 2010-09-30 | -90.53% |
| 2010-06-30 | -133.84% |
| 2010-03-31 | -9.95% |
| 2009-12-31 | 27.60% |
| 2009-09-30 | -100.75% |
| 2009-06-30 | -181.41% |
| 2009-03-31 | -213.17% |
| 2008-12-31 | 29.41% |
| 2008-09-30 | -101.14% |
| 2008-06-30 | -477.96% |
| 2008-03-31 | -121.64% |
| 2007-12-31 | -8.11% |
| 2007-09-30 | -53.68% |
| 2007-06-30 | -51.79% |
| 2007-03-31 | -96.35% |
| 2006-12-31 | -480.41% |
| 2006-09-30 | -871.68% |
| 2006-06-30 | -647.18% |
| 2006-03-31 | -1022.31% |
| 2005-12-31 | -34316.23% |
| 2005-09-30 | -23890.63% |
| 2005-06-30 | -9737.93% |
| 2005-03-31 | -13768.29% |
| 2004-12-31 | 1597.44% |
| 2004-09-30 | -1961.48% |
| 2004-06-30 | -2330.41% |
| 2004-03-31 | -3017.68% |
| 2003-12-31 | -387.83% |
| 2003-09-30 | -1535.59% |
| 2003-06-30 | -1222.56% |
| 2003-03-31 | -905.19% |
| 2002-12-31 | -754.62% |
| 2002-09-30 | -828.88% |
